Betaseron Side Effects May Lead To Hepatic Failure Lawsuits
Betaseron Side Effects Hepatic Toxicity. The FDA approved Betaseron on July 23, 1993. Betaseron is approved for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbation's. On April 22, 2005 healthcare professionals were warned regarding the prescribing information for Betaseron … [Read more...]
Betaseron Hepatoxicity Reminder
Betaseron Pertains To Hepatic Toxicity. Berlex, Inc. reminded healthcare professionals of the prescribing information for ‘Betaseron’ (interferon beta-1b) as it pertains to hepatic toxicity. ‘Betaseron’ is approved for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical … [Read more...]
